AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Bottom 1%
#4584 out of 4595 analysts
Average Return
-6.63%
Win Rate
42%136 out of 326
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cantel Medical CorpCMD | +158.06% | $31.93 | $82.40 | 2020-05-12 - 2021-01-13 | Buy |
Hologic IncHOLX | +102.55% | $34.06 | $68.99 | 2020-04-02 - 2020-11-20 | Buy |
Shockwave Medical IncSWAV | +87.86% | $178.19 | $334.75 | 2023-11-07 - 2024-05-30 | Buy |
Artivion IncAORT | +65.85% | $14.23 | $23.60 | 2023-11-03 - 2024-05-31 | Buy |
Surmodics IncSRDX | +59.86% | $26.31 | $42.06 | 2023-06-13 - 2024-05-31 | Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Stryker CorpSYK | 1 | Buy | $392.00 | +14.93% | Upgrades | 12 days ago |
Oncocyte CorpOCX | 12 | Buy | $4.25 | +55.11% | Reiterates | 18 days ago |
Lucid Diagnostics IncLUCD | 14 | Buy | $2.50 | +180.90% | Reiterates | 20 days ago |
Paragon 28 IncFNA | 12 | Buy | $14.00 | +82.05% | Maintains | 25 days ago |
Personalis IncPSNL | 13 | Buy | $3.50 | +169.23% | Reiterates | 25 days ago |
Veracyte IncVCYT | 11 | Buy | $27.00 | +30.12% | Maintains | a month ago |
Orthopediatrics CorpKIDS | 13 | Buy | $42.00 | +33.00% | Maintains | a month ago |
Artivion IncAORT | 16 | Buy | $30.00 | +27.12% | Maintains | a month ago |
Conmed CorpCNMD | 17 | Buy | $107.00 | +39.98% | Reiterates | a month ago |
Enovis CorpENOV | 9 | Buy | $82.00 | +63.12% | Reiterates | a month ago |
Hologic IncHOLX | 9 | Buy | $90.00 | +21.98% | Reiterates | a month ago |
Atricure IncATRC | 21 | Buy | $40.00 | +77.46% | Maintains | a month ago |
Livanova PLCLIVN | 17 | Buy | $72.00 | +17.90% | Reiterates | a month ago |
Surmodics IncSRDX | 14 | Buy | $43.00 | +2.23% | Maintains | a month ago |
Merit Medical Systems IncMMSI | 15 | Buy | $85.00 | +4.74% | Maintains | a month ago |
Inari Medical IncNARI | 4 | Buy | $57.00 | +14.00% | Maintains | a month ago |
Neogenomics IncNEO | 17 | Buy | $19.00 | +38.58% | Maintains | a month ago |
Resmed IncRMD | 7 | Buy | $236.00 | +14.38% | Maintains | a month ago |
Boston Scientific CorpBSX | 18 | Buy | $82.00 | +8.51% | Maintains | a month ago |
Shockwave Medical IncSWAV | 6 | Buy | $286.00 | -14.56% | Maintains | 4 months ago |
Masimo CorpMASI | 12 | Buy | $86.00 | -30.92% | Maintains | 7 months ago |
Axonics IncAXNX | 15 | Buy | $63.00 | -6.10% | Maintains | 7 months ago |
Inogen IncINGN | 7 | Buy | $26.00 | N/A | Reiterates | a year ago |
Teleflex IncTFX | 4 | Buy | $291.00 | N/A | Reiterates | a year ago |
Penumbra IncPEN | 4 | Buy | $300.00 | N/A | Maintains | a year ago |
Inmode LtdINMD | 8 | Buy | $60.00 | N/A | Reiterates | a year ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | 2 years ago |
Medtronic PLCMDT | 7 | Hold | N/A | N/A | Downgrades | 2 years ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 3 years ago |
Haemonetics CorpHAE | 5 | Buy | $108.00 | N/A | Maintains | 3 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 3 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 3 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 4 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.